New drug infusion targets tough cancers in early trial
NCT ID NCT07488676
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called ASP546C in people with advanced stomach, gastroesophageal junction, pancreatic, or certain other solid tumors. The drug is given as an infusion every 3 weeks. The study has two parts: Part 1 finds the best dose in stomach/GEJ cancer patients, and Part 2 tests that dose in pancreatic and other tumor types. The goal is to see if the drug can shrink tumors and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Cancer Center Durham
RECRUITINGDurham, North Carolina, 27710, United States
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, Japan
-
National Cancer Center Hospital East
RECRUITINGKashiwa-shi, Chiba, Japan
-
Next Oncology - Austin
RECRUITINGAustin, Texas, 78758, United States
-
Next Oncology - Dallas
RECRUITINGIrving, Texas, 75039, United States
-
Next Oncology - Houston
RECRUITINGHouston, Texas, 77054, United States
-
START Los Angeles
RECRUITINGLos Angeles, California, 90025, United States
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START Mountain Region
RECRUITINGWest Valley City, Utah, 84119, United States
-
START New York
RECRUITINGLake Success, New York, 10042, United States
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
The Cancer Institute Hospital of JFCR
RECRUITINGKoto-ku, Tokyo, Japan